[1] Invernizzi P,Selmi C,Gershwin ME.Update on primary biliary cirrhosis.Dig Liver Dis,2010,42: 401-408.
[2] Yang CY,Ma X,Tsuneyama K,et al. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy. Hepatology,2014,59:1944-1953.
[3] Tang M,Shi XH,Zhang FC.The characteristics of peripheral lymphocytic subsets and cytokines in primary biliary and their changes to drug treatment. Zhonghua Nei Ke Za Zhi,2010,49:129-133.
[4] 汪群英,徐芸,李建生,等.原发性胆汁性肝硬化患者外周血T细胞表型及细胞因子的变化及意义.临床荟萃,2008,23:477-481.
[5] Hirschfield GM,Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol,2013,8:303-830.
[6] 王磊,杜慧慧,张玮,等.原发性胆汁性肝硬化患者肝脏雌激素受体与外周血细胞因子及自身抗体的相关性研究.中华肝脏病杂志, 2012,20:336-339.
[7] Ichiki Y,Selmi C,Shimoda S,et al. Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis.Clin RevAllergy Immunol,2005,28:83-91.
[8] Youwen T,Tengli P,Yun Y,et al.Serum microRNAs as potential biomarkers of primary biliary cirrhosis. PLoS One,2014,9:e111424.
[9] Qin B,Huang F,Liang Y,et al. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Gastroenterol Hepatol,2013, 28: 543-550.
[10] Lu LF,Boldin MP,Chaudhry A,et al.Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.Cell,2010,142: 914-929.
[11] 韩志君,孙懿,胡志德,等.miR-146a对原发性胆汁性肝硬化辅助性T细胞增殖调控作用的研究.中华风湿病学杂志,2012,16:541-544.
[12] 黄元兰,陈燕,孙懿,等.miR-146a调节原发性胆汁性肝硬化患者单核细胞对LPS以及Poly I:C的反应.中华微生物学和免疫学杂志,2013,33:339-345.
[13] Katsushima F,Takahashi A,Sakamoto N,et al.Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients.Hepatol Res,2014,44:E189-197.
[14] Rodriguez A,Vigorito E,Clare S,et al.Requirement of bic/microRNA-155 for normal immune function. Science,2007,316:608-611.
[15] Banerjee A,Schambach F,DeJong CS,et al.Micro-RNA-155 inhibits IFN-γ signaling in CD4+T cell.Eur J Immunol,2010,40:225-231.
[16] Sawant DV,Wu H,Kaplan MH,et al. The Bcl6 target gene microRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway.Mol Immunol,2013,54:435-442.
[17] Lu TX,Hartner J,Lim EJ,et al.MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol,2011,187:3362-3373.
[18] Ando Y,Yang GX,Kenny TP,et al. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse. J Autoimmun,2013,41:111-119.
[19] Halász T,Horváth G,Pár G.miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.World J Gastroenterol,2015,21:7814-7823.
[20] Okoye IS,Coomes SM,Pelly VS,et al. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity,2014,41:89-103.
[21] Qian C,Wang HZ,Fan HJ,et al.MicroRNA?profiling in T cells of peripheral blood mononuclear cell from patients with?primary biliary cirrhosis.Zhonghua Yi Xue Za Zhi,2012,92:2265-2267.
[22] Qian C,Chen SX,Ren CL,et al.Abnormal expression of miR-let-7b in primary biliary cirrhosis and its clinical significance.Zhonghua Gan Zang Bing Za Zhi,2013,21:533-536.
[23] Banales JM,Sáez E,Uriz M,et al.Upregulation of mir-506 leads to decreased AE2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology,2012,56:687-697.
[24] Du R,Sun WJ,Xia L,et al. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the notch signaling pathway in tubular epithelial cells. Plos One,2012,7:e30771-e30771.
[25] Munoz GP,Hijona E,Carracedo M,et al. MicroRNAs in biliary diseases. World J Gastroenterol,2012,18:6189-6196.
[26] 潘腾莉,孙莉,周兴蓓,等.血清microRNA 表达谱对原发性胆汁性肝硬化的诊断价值.江苏大学学报( 医学版),2014,24:230-234.
[27] Padgett KA,Lan RY,Leung PC,et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun,2009, 32:246-253.
[28] Liang DY,Hou YQ,Luo LJ,et al. Altered expression of miR-92a correlates with Th17cell frequency in patients with primary biliary cirrhosis. Int J Mol Med,2016,38: 131-138.
[29] Masashi N,Yasuteru K,Ryo F,et al.Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. Plos One,2013, 8:e66086-e66086.
[30] Katsumi T,Ninomiya M,Nishina T,et al.MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis.Lab Invest,2016,96:1165-1177. |
